Daxor (NYSE:DXR) announced it will be exhibiting at an upcoming heart medical conference.
As quoted in the press release:
Heart Failure Society of America (HFSA) is well recognized as an outstanding forum for the presentation of the latest information on clinical and basic research, treatment and patient care in heart failure (HF), and is attended by key thought leaders and decision makers in the field.
At the meeting, Daxor will be highlighting the clinical and resource utilization outcomes benefits shown to be achievable with individualized care guided by direct blood volume analysis (BVA) in the setting of acute heart failure (AHF). Company leadership also will be meeting with key investigators and opinion leaders regarding clinical research strategies and upcoming data dissemination initiatives during the course of the conference.